CreditReports.dk
HomeScreen companies

DeLiver Pharma ApS Financials, key figures and credit report

CVR number: 39432714 Established 2018 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Sanatorievej 8, 5600 Faaborg jonasgraversen@gmail.com tel: 21733311
Gross profit -20.5 kDKK FY 2025 -98.9% vs 2024
EBIT -31.9 kDKK FY 2025 -47% vs 2024
Net debt - 110.3 kDKK FY 2025 +14.1% vs 2024
Quick ratio 8.4 FY 2025 -3.3 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit-21.88-17.95118.66-10.30-20.49
Total depreciation- 125.03-11.38-11.38-11.38-11.38
EBIT- 146.91-29.33107.28-21.68-31.87
Pre-tax profit- 146.91-29.33107.28-21.68-31.87
Net earnings- 146.91-29.33107.28-21.68-31.87

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible rights99.0487.6676.2964.9153.53
Intangible assets total99.0487.6676.2964.9153.53
Tangible assets total
Participating interests12.50
Investments total12.50
Non-current loans receivable12.5012.5012.5012.50
Long term receivables total12.5012.5012.5012.50
Inventories total
Current other receivables1.4112.260.26
Short term receivables total1.4112.260.26
Cash and bank deposits36.568.33182.57128.42110.34
Cash and cash equivalents36.568.33182.57128.42110.34
Balance sheet total (assets)149.52120.75271.36206.09176.36

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital260.00260.00260.00260.00260.00
Retained earnings25.73- 121.18- 150.51-43.23-64.91
Profit of the financial year- 146.91-29.33107.28-21.68-31.87
Shareholders equity total138.82109.49216.77195.09163.22
Non-current liabilities total
Current trade creditors10.7011.2620.5411.0011.50
Other non-interest bearing current liabilities34.051.64
Current liabilities total10.7011.2654.5911.0013.14
Balance sheet total (liabilities)149.52120.75271.36206.09176.36
Page generated